Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Alirocumab |
Trade Name | |
Synonyms | Praluent |
Drug Descriptions |
Alirocumab is a monoclonal antibody that targets PCSK9, potentially leading to decreased tumor growth (PMID: 33177715). |
DrugClasses | |
CAS Registry Number | 1245916-14-6 |
NCIT ID | C174849 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Alirocumab | Alirocumab | 0 | 0 |
Alirocumab + Cemiplimab | Alirocumab Cemiplimab | 0 | 2 |